Search Results - "Njoo, M.D."

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-term drug-survival study from the BioCAPTURE registry by Zweegers, J., van den Reek, J.M.P.A., van de Kerkhof, P.C.M., Otero, M.E., Kuijpers, A.L.A., Koetsier, M.I.A., Arnold, W.P., Berends, M.A.M., Weppner-Parren, L., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., van Lümig, P.P.M., Driessen, R.J.B., Kievit, W., de Jong, E.M.G.J.

“…Summary Background Predictors for successful treatment are important for personalized medicine. Predictors for drug survival of biologics in psoriasis have…”
Get full text

Female patients are less satisfied with biological treatment for psoriasis and experience more side‐effects than male patients: results from the prospective BioCAPTURE registry by van der Schoot, L.S., van den Reek, J.M.P.A., Groenewoud, J.M.M., Otero, M.E., Njoo, M.D., Ossenkoppele, P.M., Mommers, J.M., Koetsier, M.I.A., Berends, M.A.M., Arnold, W.P., Peters, B., Andriessen, M.P.M., Den Hengst, C.W., Kuijpers, A.L.A., de Jong, E.M.G.J.

“…Background Female sex has been reported as a predictor for treatment discontinuation with biological therapies for psoriasis, although reasons remain unclear…”
Get full text

Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort by Zweegers, J., Roosenboom, B., Kerkhof, P.C.M., Reek, J.M.P.A., Otero, M.E., Atalay, S., Kuijpers, A.L.A., Koetsier, M.I.A., Arnold, W.P., Berends, M.A., Weppner‐Parren, L., Bijen, M., Njoo, M.D., Mommers, J.M., Lümig, P.P.M., Driessen, R.J.B., Kievit, W., Jong, E.M.G.J.

“…Summary Background It is important to assess which patients with psoriasis are more likely to achieve high clinical responses on biologics. Objectives To…”
Get full text

Twenty‐year follow‐up using a postal survey of childhood vitiligo treated with narrowband ultraviolet B phototherapy by Lommerts, J.E., Njoo, M.D., Rie, M.A., Wolkerstorfer, A., Bekkenk, M.W.

Get full text

Body mass index predicts discontinuation due to ineffectiveness and female sex predicts discontinuation due to side-effects in patients with psoriasis treated with adalimumab, etanercept or ustekinumab in daily practice: a prospective, comparative, long-t by Zweegers, J., van den Reek, J.M.P.A., van de Kerkhof, P.C.M., Otero, M.E., Kuijpers, A.L.A., Koetsier, M.I.A., Arnold, W.P., Berends, M.A.M., Weppner-Parren, L., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., van Lümig, P.P.M., Driessen, R.J.B., Kievit, W., de Jong, E.M.G.J.

Get full text

Comparing treatment goals for psoriasis with treatment decisions in daily practice: results from a prospective cohort of patients with psoriasis treated with biologics: Bio CAPTURE by Zweegers, J., Reek, J.M.P.A., Kerkhof, P.C.M., Otero, M.E., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., Koetsier, M.I.A., Arnold, W.P., Sybrandy‐Fleuren, B.A.M., Kuijpers, A.L.A., Andriessen, M.P.M., Kievit, W., Jong, E.M.G.J.

Get full text

‘Happy’ drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the Bio CAPTURE network by Reek, J.M.P.A., Zweegers, J., Kievit, W., Otero, M.E., Lümig, P.P.M., Driessen, R.J.B., Ossenkoppele, P.M., Njoo, M.D., Mommers, J.M., Koetsier, M.I.A., Arnold, W.P., Sybrandy‐Fleuren, B.A.M., Kuijpers, A.L.A., Andriessen, M.P.M., Kerkhof, P.C.M., Seyger, M.M.B., Jong, E.M.G.J.

Get full text

Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy by Njoo, M.D., Bos, J.D., Westerhof, W.

“…Background: Only a few clinical trials have been performed on the treatment of generalized vitiligo in children. Recently, narrow-band UVB therapy has been…”
Get full text

Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser by Njoo, M.D., Vodegel, R.M., Westerhof, W.

“…Background: Monobenzylether of hydroquinone is used worldwide to remove residual pigment in patients with vitiligo universalis. Because of the side effects…”
Get full text

Association of the koebner phenomenon with disease activity and therapeutic responsiveness in vitiligo vulgaris by Njoo, M.D., Das, P.K., Bos, J.D., Westerhof, W.

Get full text

N-Acetylcysteine as a bleaching agent in the treatment of melasma by Njoo, M.D., Menke, H.E., Pavel, S., Westerhof, W.

Get full text

N-acetylcysteine as a bleaching agent in the treatment of melasma by Njoo, M.D., Menke, H.E., Pavel, S., Westerhof, W.

Get full text